Results 271 to 280 of about 1,200,697 (382)

Protocol-Specific Outcomes of GnRH Agonist Use in Luteal Phase Support During Frozen Embryo Transfer Cycles. [PDF]

Int J Womens Health
Salame A, Dahdouh EM, Zhaffal M, Al Jafari R, Muraleekrishnan A, Bajpai A, Kainoth S, Koodathingal BP, Samuel D, Depret-Bixio L, Fakih M.   +10 more
europepmc   +1 more source

Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT_2C Receptor Agonists

, 2015
Guy Rouquet, Dianna E. Moore, Malcolm Spain, Daniel M. Allwood, Claudio Battilocchio, David C. Blakemore, Paul V. Fish, Stephen Jenkinson, Alan S. Jessiman, Steven V. Ley, Gordon McMurray, Richard Storer   +11 more
openalex   +1 more source

Agonist [PDF]

, 2020
openaire   +1 more source

Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.

JAMA Internal Medicine, 2014
T. Moore, Joseph Glenmullen, D. Mattison
semanticscholar   +1 more source

Polysaccharide Adjuvants as Innate Immune Trainers: Bridging Pattern Recognition Receptor (PRR) Activation and Metabolic Reprogramming for Synthetic Vaccine Design

Advanced Science, EarlyView.
Polysaccharides modulate immune responses by engaging pattern recognition receptors (PRRs) to induce T‐cell activation. In vaccine design, their particle size critically influences lymph node targeting and activation mechanisms. By engineering structural complexity and multivalent PRR engagement, polysaccharides enable precise modulation of immune ...
Jeong Hyun Moon, May Thazin Phoo, Yubin Kim, Jinsung Ahn, April Kim, Jutaek Nam, Soo‐Hong Lee, James J. Moon, Sejin Son   +8 more
wiley   +1 more source

Visualizing joint force-velocity properties in musculoskeletal models. [PDF]

R Soc Open Sci
Richards C, Murtola T.
europepmc   +1 more source

Agonist Medications for the Treatment of Cocaine Use Disorder

Neuropsychopharmacology, 2015
S. Negus, J. Henningfield
semanticscholar   +1 more source

Hyaluronic Acid Hydrogel Implants for Sustained Release of Oxaliplatin and Resiquimod to Prevent Hepatocellular Carcinoma Recurrence Post‐Radiofrequency Ablation

Advanced Science, EarlyView.
Preparation of a biopolymer‐based immune implant (BI) for the sustained release of R848 and oxaliplatin (OXA), enabling immune activation and preventing recurrence after radiofrequency ablation (RFA) treatment in hepatocellular carcinoma (HCC). Abstract Hepatocellular carcinoma (HCC) remains a global challenge due to limited therapies and high ...
Yuezhan Shan, Hongyu Chu, Sheyu Ye, Guofeng Ji, Jiayi Zhao, Xinghui Si, Yumin Zhong, Youmao Tao, Jingwei Shi, Xuedong Fang   +9 more
wiley   +1 more source

Integration of TLR7/8 agonists into lipid nanoparticles enhances antigen-specific immune responses to N1-methyl-Ψ-modified mRNA-LNP vaccines. [PDF]

J Biol Eng
Choi H, Lee S, Kim H, Bae SH, Jo S, Kim J, Lee Y, Ha D, Oh A, Yoon S, Jeon S, Lee YS, Cho Y, Cho S, Roh G, Lee S, Gowda J, Park HJ, Lee J, Song D, Hong SH, Han SB, Nam JH.   +22 more
europepmc   +1 more source

Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.

Cochrane Database of Systematic Reviews, 2014
M. A. Youssef, F. van der Veen, H. Al-Inany, M. Mochtar, G. Griesinger, Mohamed Nagi Mohesen, Ismail Aboulfoutouh, M. van Wely   +7 more
semanticscholar   +1 more source